Dysbioses of the microbiota
This very recent term is made up by combining two Greek words:
- ‘dys’, which signifies difficulty, and
- ‘bios’, which refers to life resources.
In medicine, this term is exclusively used to qualify a microbiota imbalance in relation to a harmonious distribution of microorganisms for an optimum health1.
Dysbioses are not exclusive to the human microbiota but can also be extended to all living beings that are hosts appreciated by microorganisms.
From disruption to resilience
The microbiota can change according to many disruptive events. These elements include but are not limited to:
- poor diet,
- dietary change,
- physical or psychological stress,
- extreme temperatures,
- altered intestinal movement, drug intake especially antibiotics.
Naturally resilient, the microbiota tends to restore it to the personal configuration specific of each of us, i.e. returning to primary equilibrium2.
Dysbiosis and diseases
During the last years, scientists have become increasingly aware that a state of dysbiosis is associated with numerous diseases and may cause certain diseases.
1 Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65: 330-339.
2 Landman C, Quévrain E. [Gut microbiota: Description, role and pathophysiologic implications]. Rev Med Interne. 2016; 37: 418-423.
3 Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859-904.
4 Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2014; 13: 17-22.
5 Moraes-Filho JP, Quigley EM. The intestinal microbiota abd the role of probiotics in irritable bowel syndrome: a review. Arq Gastroenterol. 2015; 52: 331-338.
6 Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015; 5(Suppl 1): S29-36.
7 Ahluwalia V, Betrapally NS, Hylemon PB, White MB, Gillevet PM, Unser AB, Fagan A, Daita K, Heuman DM, Zhou H, Sikaroodi M, Bajaj JS. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Sci Rep. 2016; 6: 26800.
8 Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry. 2016; 21: 738-748.
9 Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003; 79: 428-432.
10 Kern AM, Bohbot JM, Cardot JM. Preventive treatment of vulvovaginal candidiasis with a vaginal probiotic (Gynophilus®-Lcr Regenerans®): results of the candiflore observational study. La Lettre du Gynécologue. 2012; 370: 34-37.
11 Bautista CT, Wurapa E, Sateren WB, Morris S, Hollingsworth B, Sanchez JL. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016; 3: 4.
12 Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015; 17: 592-602.
13 Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol. 2016; 78: 481-504.
14 Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011; 9: 244-253.